David C. LaFon

815 total citations
15 papers, 146 citations indexed

About

David C. LaFon is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, David C. LaFon has authored 15 papers receiving a total of 146 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in David C. LaFon's work include Pneumonia and Respiratory Infections (6 papers), Respiratory viral infections research (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). David C. LaFon is often cited by papers focused on Pneumonia and Respiratory Infections (6 papers), Respiratory viral infections research (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). David C. LaFon collaborates with scholars based in United States, Denmark and United Kingdom. David C. LaFon's co-authors include Moon H. Nahm, Young Keun Kim, Mark T. Dransfield, Young-il Kim, Françoise Gaillard, Steffen Thiel, F Patte, Laurent Garel, Duygu Ucar and Karolina Palucka and has published in prestigious journals such as Nature Immunology, Vaccine and Journal of Immunological Methods.

In The Last Decade

David C. LaFon

14 papers receiving 145 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David C. LaFon United States 8 68 46 33 20 18 15 146
Daniela Guerreiro United Kingdom 6 77 1.1× 16 0.3× 38 1.2× 13 0.7× 24 1.3× 16 152
Mark Pulletz United Kingdom 3 46 0.7× 77 1.7× 22 0.7× 10 0.5× 10 0.6× 3 115
Deborah Whitters United Kingdom 4 30 0.4× 17 0.4× 54 1.6× 20 1.0× 14 0.8× 4 113
Carole Hancock United Kingdom 5 76 1.1× 21 0.5× 10 0.3× 18 0.9× 19 1.1× 7 114
Furkan Guvenc Canada 6 34 0.5× 18 0.4× 17 0.5× 24 1.2× 17 0.9× 8 107
Paolo Donato Italy 5 23 0.3× 24 0.5× 33 1.0× 29 1.4× 20 1.1× 7 146
Byron Brook United States 8 36 0.5× 91 2.0× 21 0.6× 31 1.6× 7 0.4× 15 152
Ayşen Bingöl Türkiye 6 19 0.3× 15 0.3× 23 0.7× 11 0.6× 11 0.6× 31 111
К. О. Миронов Russia 6 67 1.0× 19 0.4× 11 0.3× 29 1.4× 37 2.1× 64 142
María José Currás-Tuala Spain 6 42 0.6× 27 0.6× 19 0.6× 74 3.7× 3 0.2× 16 150

Countries citing papers authored by David C. LaFon

Since Specialization
Citations

This map shows the geographic impact of David C. LaFon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. LaFon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. LaFon more than expected).

Fields of papers citing papers by David C. LaFon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. LaFon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. LaFon. The network helps show where David C. LaFon may publish in the future.

Co-authorship network of co-authors of David C. LaFon

This figure shows the co-authorship network connecting the top 25 collaborators of David C. LaFon. A scholar is included among the top collaborators of David C. LaFon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. LaFon. David C. LaFon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tipper, Jennifer L., Ahmed Lazrak, Abel G. López, et al.. (2025). Endoplasmic Reticulum Stress Disrupts the Airway Epithelium and Reduces Host Defense during Influenza A Virus Infection. American Journal of Respiratory Cell and Molecular Biology. 74(1). 40–51. 1 indexed citations
2.
Díaz, Fernando Erra, Emin Onur Karakaslar, Radu Marcheş, et al.. (2024). Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults. Nature Immunology. 25(2). 316–329. 12 indexed citations
3.
LaFon, David C., Erika S. Helgeson, Sarah Lindberg, et al.. (2024). β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction. JAMA Network Open. 7(5). e247535–e247535. 2 indexed citations
4.
LaFon, David C., Steffen Thiel, Young-il Kim, Mark T. Dransfield, & Moon H. Nahm. (2021). Correction to: Classical and lectin complement pathways and markers of inflammation for investigation of susceptibility to infections among healthy older adults. Immunity & Ageing. 18(1). 1 indexed citations
5.
Sterrett, Sarah, Robert L. Burton, David C. LaFon, et al.. (2020). Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individuals. Vaccine. 38(7). 1778–1786. 19 indexed citations
6.
Dransfield, Mark T., Courtney Crim, Gerard J. Criner, et al.. (2020). Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT. Annals of the American Thoracic Society. 18(5). 788–798. 16 indexed citations
7.
LaFon, David C., Steffen Thiel, Young-il Kim, Mark T. Dransfield, & Moon H. Nahm. (2020). Classical and lectin complement pathways and markers of inflammation for investigation of susceptibility to infections among healthy older adults. Immunity & Ageing. 17(1). 18–18. 7 indexed citations
8.
LaFon, David C., Nirupama Putcha, Nadia N. Hansel, et al.. (2020). Reduced Pneumococcal Antibody Function Is Associated with Exacerbations of COPD in SPIROMICS. A2549–A2549.
9.
LaFon, David C. & Moon H. Nahm. (2018). Measuring immune responses to pneumococcal vaccines. Journal of Immunological Methods. 461. 37–43. 38 indexed citations
10.
LaFon, David C. & Moon H. Nahm. (2018). Measuring quantity and function of pneumococcal antibodies in immunoglobulin products. Transfusion. 58(S3). 3114–3120. 8 indexed citations
11.
Kim, Young Keun, David C. LaFon, & Moon H. Nahm. (2016). Indirect Effects of Pneumococcal Conjugate Vaccines in National Immunization Programs for Children on Adult Pneumococcal Disease. Infection and Chemotherapy. 48(4). 257–257. 20 indexed citations
13.
Jarrige, Nathalie, et al.. (2006). Potential sources of infection for BSE cases born in France after 1996. Veterinary Record. 159(9). 285–286. 4 indexed citations
14.
Bismuth, C, et al.. (1988). [Chronic abuse of the analgesic nefopam (Acupan)].. PubMed. 7(5). 343–6. 2 indexed citations
15.
Patte, F, et al.. (1973). [Spontaneous pneumothorax. Clinical study, meteorological correlations, course and treatment].. PubMed. 36(3). 431–46. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026